Search

everythinglearnresearchcommunity

for

Search:↓

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Co-trimoxazole may help treat autoimmune diseases.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Early NAS level changes affect alcohol consumption vulnerability.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Pulsed electric field treatment may help shrink untreated liver tumors.

Calancardin B may help reduce inflammation in immune cells.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

A new microneedle system effectively delivers finasteride to treat hair loss.